How AI Is Already Reshaping Cancer Care
When treating cancer, timing is everything. AI is helping identify clinical trial participants earlier, accelerate discovery, and expand access to investigational therapies.
How AI Is Already Reshaping Cancer Care
When treating cancer, timing is everything. AI is helping identify clinical trial participants earlier, accelerate discovery, and expand access to investigational therapies.
Spotting the Signs of ATTR-CM: Latest Data Reveals Opportunities for More Timely Detection
For many people living with transthyretin amyloid cardiomyopathy (ATTR‑CM) – a rare and underdiagnosed cause of heart failure – receiving an accurate diagnosis can be a long and uncertain journey.
Spotting the Signs of ATTR-CM: Latest Data Reveals Opportunities for More Timely Detection
For many people living with transthyretin amyloid cardiomyopathy (ATTR‑CM) – a rare and underdiagnosed cause of heart failure – receiving an accurate diagnosis can be a long and uncertain journey.
As Colorectal Cancer Rises in Younger Populations, Research and Education is More Important than Ever
At one time, colorectal cancer was a disease associated with older adults. Now, it’s considered the most deadly cancer in people younger than 50.
As Colorectal Cancer Rises in Younger Populations, Research and Education is More Important than Ever
At one time, colorectal cancer was a disease associated with older adults. Now, it’s considered the most deadly cancer in people younger than 50.
One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options
Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.
One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options
Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.
How Innovative Diagnostics Are Supporting a Potential Approach to C. difficile
When scientists design a new vaccine candidate, they must also identify diagnostic tests that can be used to measure how effective that vaccine is.
How Innovative Diagnostics Are Supporting a Potential Approach to C. difficile
When scientists design a new vaccine candidate, they must also identify diagnostic tests that can be used to measure how effective that vaccine is.
How AI Is Already Reshaping Cancer Care
When treating cancer, timing is everything. AI is helping identify clinical trial participants earlier, accelerate discovery, and expand access to investigational therapies.
How AI Is Already Reshaping Cancer Care
When treating cancer, timing is everything. AI is helping identify clinical trial participants earlier, accelerate discovery, and expand access to investigational therapies.
Spotting the Signs of ATTR-CM: Latest Data Reveals Opportunities for More Timely Detection
For many people living with transthyretin amyloid cardiomyopathy (ATTR‑CM) – a rare and underdiagnosed cause of heart failure – receiving an accurate diagnosis can be a long and uncertain journey.
Spotting the Signs of ATTR-CM: Latest Data Reveals Opportunities for More Timely Detection
For many people living with transthyretin amyloid cardiomyopathy (ATTR‑CM) – a rare and underdiagnosed cause of heart failure – receiving an accurate diagnosis can be a long and uncertain journey.
As Colorectal Cancer Rises in Younger Populations, Research and Education is More Important than Ever
At one time, colorectal cancer was a disease associated with older adults. Now, it’s considered the most deadly cancer in people younger than 50.
As Colorectal Cancer Rises in Younger Populations, Research and Education is More Important than Ever
At one time, colorectal cancer was a disease associated with older adults. Now, it’s considered the most deadly cancer in people younger than 50.
One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options
Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.
One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options
Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.
How Innovative Diagnostics Are Supporting a Potential Approach to C. difficile
When scientists design a new vaccine candidate, they must also identify diagnostic tests that can be used to measure how effective that vaccine is.
How Innovative Diagnostics Are Supporting a Potential Approach to C. difficile
When scientists design a new vaccine candidate, they must also identify diagnostic tests that can be used to measure how effective that vaccine is.